Weatherford (WFRD) came out with quarterly earnings of $2.06 per share, beating the Zacks Consensus Estimate of $1.65 per share. This compares to earnings of $1.66 per share a year ago.
Weatherford (WFRD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Weatherford International plc (NASDAQ:WFRD ) Q2 2024 Earnings Conference Call July 24, 2024 9:00 AM ET Company Participants Mohammed Topiwala - Vice President, Investor Relations & M&A Girish Saligram - President & Chief Executive Officer Arun Mitra - Executive Vice President & Chief Financial Officer Conference Call Participants Luke Lemoine - Piper Sandler James West - Evercore David Anderson - Barclays Ati Modak - Goldman Sachs Jim Rollyson - Raymond James Scott Gruber - Citigroup Doug Becker - Capital One Kurt Hallead - Benchmark Saurabh Pant - Bank of America Operator Good day, and welcome to the Weatherford Second Quarter 2024 Results Conference Call. All participants will be in a listen-only mode.
Weatherford (WFRD) came out with quarterly earnings of $1.66 per share, missing the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.12 per share a year ago.
Weatherford (WFRD) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Weatherford (WFRD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Weatherford stock has had a remarkable rise over a three-year period, but I want to make the case that price history should not cloud an investment decision. The company is firing on all cylinders and management has a good grip on the business and its profitability. I value the company through three lenses and find it an attractive buy at present levels.